ANONDITA MEDICARE LIMITED vs MARICO LIMITED
A side-by-side comparison of ANONDITA MEDICARE LIMITED (ANONDITA) and MARICO LIMITED (MARICO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, MARICO LIMITED leads ANONDITA vs MARICO on 7 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation31
- Profitability22
- Growth· not comparable—
- Size & financial health04
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
ANONDITA takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
MARICO takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- − ["Stock is trading at 15.2 times its book value", "Though the company is reporting repeated profits, it is not paying out dividend"]
- + ["Company has a good return on equity (ROE) track record: 3 Years ROE 40.9%", "Company has been maintaining a healthy dividend payout of 65.1%"]
- − ["Stock is trading at 25.6 times its book value", "The company has delivered a poor sales growth of 11.1% over past five years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.